Psoas abscess is commonly caused by Staphylococcus, which is the likely culprit in this case. The patient’s lumbar tenderness and preference for a slightly flexed knee position are indicative of this condition, which is particularly risky for individuals with immunosuppression due to factors such as intravenous drug use, diabetes, or HIV. Given the patient’s recent groin abscess, it is possible that the organism responsible for that infection seeded the psoas muscle. It is important to be aware of potential complications of Staphylococcus aureus infection, such as infective endocarditis and psoas abscess, and to investigate these conditions in patients with positive blood cultures for this organism.

An iliopsoas abscess is a condition where pus accumulates in the iliopsoas compartment, which includes the iliacus and psoas muscles. There are two types of iliopsoas abscesses: primary and secondary. Primary abscesses occur due to the spread of bacteria through the bloodstream, with Staphylococcus aureus being the most common cause. Secondary abscesses are caused by underlying conditions such as Crohn’s disease, diverticulitis, colorectal cancer, UTIs, GU cancers, vertebral osteomyelitis, femoral catheterization, lithotripsy, endocarditis, and intravenous drug use. Secondary abscesses have a higher mortality rate compared to primary abscesses.

The clinical features of an iliopsoas abscess include fever, back/flank pain, limp, and weight loss. During a clinical examination, the patient is positioned supine with the knee flexed and the hip mildly externally rotated. Specific tests are performed to diagnose iliopsoas inflammation, such as placing a hand proximal to the patient’s ipsilateral knee and asking the patient to lift their thigh against the hand, which causes pain due to contraction of the psoas muscle. Another test involves lying the patient on the normal side and hyperextending the affected hip, which should elicit pain as the psoas muscle is stretched.

The investigation of choice for an iliopsoas abscess is a CT scan of the abdomen. Management involves antibiotics and percutaneous drainage, which is successful in around 90% of cases. Surgery is only indicated if percutaneous drainage fails or if there is another intra-abdominal pathology that requires surgery.

Exercise is known to improve inflammatory back pain, such as that seen in ankylosing spondylitis. This type of pain is typically worse in the morning or with rest, but eases with physical activity. Other causes of inflammatory back pain include rheumatoid arthritis. Difficulty with activities of daily living and insidious onset are non-specific and may be seen in other types of back pain. Ankylosing spondylitis is more common in men, but can still occur in women.

Ankylosing spondylitis is a type of spondyloarthropathy that is associated with HLA-B27. It is more commonly seen in young males, with a sex ratio of 3:1, and typically presents with lower back pain and stiffness that develops gradually. The stiffness is usually worse in the morning and improves with exercise, while pain at night may improve upon getting up. Clinical examination may reveal reduced lateral and forward flexion, as well as reduced chest expansion. Other features associated with ankylosing spondylitis include apical fibrosis, anterior uveitis, aortic regurgitation, Achilles tendonitis, AV node block, amyloidosis, cauda equina syndrome, and peripheral arthritis (more common in females).

The revised ARA criteria for the classification of lupus includes serositis (pleuritis or pericarditis) as a defining feature. Pericarditis is the most prevalent cardiac manifestation of SLE and is also included in the classification criteria of the British Society for Rheumatology 2018 guidelines for SLE. It is important to note that the other options are not part of these criteria, which are not comprehensive but are still considered a valuable diagnostic aid.

Understanding Systemic Lupus Erythematosus

Systemic lupus erythematosus (SLE) is an autoimmune disorder that affects multiple systems in the body. It is more common in women and people of Afro-Caribbean origin, and typically presents in early adulthood. The general features of SLE include fatigue, fever, mouth ulcers, and lymphadenopathy.

SLE can also affect the skin, causing a malar (butterfly) rash that spares the nasolabial folds, discoid rash in sun-exposed areas, photosensitivity, Raynaud’s phenomenon, livedo reticularis, and non-scarring alopecia. Musculoskeletal symptoms include arthralgia and non-erosive arthritis.

Cardiovascular manifestations of SLE include pericarditis and myocarditis, while respiratory symptoms may include pleurisy and fibrosing alveolitis. Renal involvement can lead to proteinuria and glomerulonephritis, with diffuse proliferative glomerulonephritis being the most common type.

Finally, neuropsychiatric symptoms of SLE may include anxiety and depression, as well as more severe manifestations such as psychosis and seizures. Understanding the various features of SLE is important for early diagnosis and management of this complex autoimmune disorder.

When a patient with a history of cancer complains of back pain, it is important to investigate further. Even if the pain seems to be caused by a simple musculoskeletal injury, there may be underlying issues related to the patient’s cancer history. In this case, the patient has three red flags that require urgent attention in a hospital setting: a history of cancer, thoracic back pain, and worsening pain when lying down (which could indicate pressure on a growth or tumor). The concern is that the back pain may be caused by spinal metastases, which can lead to cord compromise.

Performing a digital rectal exam (DRE) is not necessary in this case, as the patient does not exhibit symptoms of cauda equina syndrome or cord compromise. DRE is typically used to assess for reduced anal tone and saddle anesthesia, which are signs of cauda equina syndrome. This condition can cause sciatic-like lower back and leg pain.

While prescribing stronger pain medication may help alleviate the patient’s symptoms, the priority in managing this case is to rule out any serious underlying causes of the back pain. Physiotherapy may be helpful in managing musculoskeletal back pain, but it is important to first rule out the possibility of spinal metastases due to cancer recurrence.

An X-ray of the spine may not be sensitive enough to detect small lytic lesions or assess for canal compromise. It is typically only considered if there has been recent significant trauma or suspicion of osteoporotic vertebral collapse. In cases where metastases are suspected, an MRI or CT scan is preferred.

Lower back pain is a common issue that is often caused by muscular strain. However, it is important to be aware of potential underlying causes that may require specific treatment. Certain red flags should be considered, such as age under 20 or over 50, a history of cancer, night pain, trauma, or systemic illness. There are also specific causes of lower back pain that should be kept in mind. Facet joint pain may be acute or chronic, worse in the morning and on standing, and typically worsens with back extension. Spinal stenosis may cause leg pain, numbness, and weakness that is worse on walking and relieved by sitting or leaning forward. Ankylosing spondylitis is more common in young men and causes stiffness that is worse in the morning and improves with activity. Peripheral arterial disease may cause pain on walking and weak foot pulses. It is important to consider these potential causes and seek appropriate diagnosis and treatment.

If a patient has a known allergy to a sulfa drug like co-trimoxazole, they should avoid taking sulfasalazine. However, hydroxychloroquine, leflunomide, methotrexate, and sarilumab are not contraindicated for this patient. These drugs may be considered as first-line treatments for rheumatoid arthritis, depending on the patient’s disease activity and response to other medications. It is important to note that sulfasalazine should be avoided in patients with a sulfa drug allergy.

Sulfasalazine: A DMARD for Inflammatory Arthritis and Bowel Disease

Sulfasalazine is a type of disease modifying anti-rheumatic drug (DMARD) that is commonly used to manage inflammatory arthritis, particularly rheumatoid arthritis, as well as inflammatory bowel disease. This medication is a prodrug for 5-ASA, which works by reducing neutrophil chemotaxis and suppressing the proliferation of lymphocytes and pro-inflammatory cytokines.

However, caution should be exercised when using sulfasalazine in patients with G6PD deficiency or those who are allergic to aspirin or sulphonamides due to the risk of cross-sensitivity. Adverse effects of sulfasalazine may include oligospermia, Stevens-Johnson syndrome, pneumonitis/lung fibrosis, myelosuppression, Heinz body anaemia, megaloblastic anaemia, and the potential to color tears and stain contact lenses.

Despite these potential side effects, sulfasalazine is considered safe to use during pregnancy and breastfeeding, making it a viable option for women who require treatment for inflammatory arthritis or bowel disease. Overall, sulfasalazine is an effective DMARD that can help manage the symptoms of these conditions and improve patients’ quality of life.

For patients with a displaced hip fracture, the preferred treatment is either hemiarthroplasty or total hip replacement. The most common type of intracapsular fracture of the proximal femur is a subcapital fracture. Fractures that occur proximal to the intertrochanteric line are classified as intracapsular, while those that occur distal to it are classified as extracapsular. Due to the potential threat to the blood supply in intracapsular fractures, the general recommendation is to perform hemiarthroplasty. For extracapsular femoral fractures, a dynamic hip screw is typically used.

Hip fractures are a common occurrence, particularly in elderly women with osteoporosis. The femoral head’s blood supply runs up the neck, making avascular necrosis a potential risk in displaced fractures. Symptoms of a hip fracture include pain and a shortened and externally rotated leg. Patients with non-displaced or incomplete neck of femur fractures may still be able to bear weight. Hip fractures can be classified as intracapsular or extracapsular, with the Garden system being a commonly used classification system. Blood supply disruption is most common in Types III and IV fractures.

Intracapsular hip fractures can be treated with internal fixation or hemiarthroplasty if the patient is unfit. Displaced fractures are recommended for replacement arthroplasty, such as total hip replacement or hemiarthroplasty, according to NICE guidelines. Total hip replacement is preferred over hemiarthroplasty if the patient was able to walk independently outdoors with the use of a stick, is not cognitively impaired, and is medically fit for anesthesia and the procedure. Extracapsular hip fractures can be managed with a dynamic hip screw for stable intertrochanteric fractures or an intramedullary device for reverse oblique, transverse, or subtrochanteric fractures.

A useful test to rule out SLE is ANA positivity, as the majority of patients with SLE are ANA positive. While CRP and ESR may rise during an acute flare of SLE, they are not specific to autoimmune conditions. ANCA is an antibody found in patients with autoimmune vasculitis.

Systemic lupus erythematosus (SLE) can be investigated through various tests, including antibody tests. ANA testing is highly sensitive, making it useful for ruling out SLE, but it has low specificity. About 99% of SLE patients are ANA positive. Rheumatoid factor testing is positive in 20% of SLE patients. Anti-dsDNA testing is highly specific (>99%), but less sensitive (70%). Anti-Smith testing is also highly specific (>99%), but only 30% of SLE patients test positive. Other antibody tests include anti-U1 RNP, SS-A (anti-Ro), and SS-B (anti-La).

Monitoring of SLE can be done through various markers, including inflammatory markers such as ESR. During active disease, CRP levels may be normal, but a raised CRP may indicate an underlying infection. Complement levels (C3, C4) are low during active disease due to the formation of complexes that lead to the consumption of complement. Anti-dsDNA titres can also be used for disease monitoring, but it is important to note that they are not present in all SLE patients. Proper monitoring of SLE is crucial for effective management of the disease.

Bisphosphonates are the recommended treatment for Paget’s disease of the bone, which is indicated by an elevated ALP level and typical x-ray findings in this patient. The PSA level of 3.4 ng/ml is within the normal range for a man of his age and does not suggest the presence of prostate cancer that has spread to other parts of the body.

Understanding Paget’s Disease of the Bone

Paget’s disease of the bone is a condition characterized by increased and uncontrolled bone turnover. It is believed to be caused by excessive osteoclastic resorption followed by increased osteoblastic activity. Although it is a common condition, affecting 5% of the UK population, only 1 in 20 patients experience symptoms. The most commonly affected areas are the skull, spine/pelvis, and long bones of the lower extremities. Predisposing factors include increasing age, male sex, northern latitude, and family history.

Symptoms of Paget’s disease include bone pain, particularly in the pelvis, lumbar spine, and femur. The stereotypical presentation is an older male with bone pain and an isolated raised alkaline phosphatase (ALP). Classical, untreated features include bowing of the tibia and bossing of the skull. Diagnosis is made through blood tests, which show raised ALP, and x-rays, which reveal osteolysis in early disease and mixed lytic/sclerotic lesions later.

Treatment is indicated for patients experiencing bone pain, skull or long bone deformity, fracture, or periarticular Paget’s. Bisphosphonates, either oral risedronate or IV zoledronate, are the preferred treatment. Calcitonin is less commonly used now. Complications of Paget’s disease include deafness, bone sarcoma (1% if affected for > 10 years), fractures, skull thickening, and high-output cardiac failure.

Overall, understanding Paget’s disease of the bone is important for early diagnosis and management of symptoms and complications.

When patients present with back pain, thoracic pain should be considered a warning sign. In this particular case, the patient’s back pain has several red-flag features, including its location in the middle of the back, sudden onset and progression, night pain, and recent prostate exam results. These symptoms are highly indicative of metastatic prostate cancer with spinal cord compression, which is a medical emergency. Immediate hospital assessment is necessary, along with a whole-body MRI and treatment such as high dose dexamethasone, radiotherapy, and surgery if needed. Any response that fails to recognize the urgency of this situation is incorrect.

Lower back pain is a common issue that is often caused by muscular strain. However, it is important to be aware of potential underlying causes that may require specific treatment. Certain red flags should be considered, such as age under 20 or over 50, a history of cancer, night pain, trauma, or systemic illness. There are also specific causes of lower back pain that should be kept in mind. Facet joint pain may be acute or chronic, worse in the morning and on standing, and typically worsens with back extension. Spinal stenosis may cause leg pain, numbness, and weakness that is worse on walking and relieved by sitting or leaning forward. Ankylosing spondylitis is more common in young men and causes stiffness that is worse in the morning and improves with activity. Peripheral arterial disease may cause pain on walking and weak foot pulses. It is important to consider these potential causes and seek appropriate diagnosis and treatment.

Dermatomyositis is often associated with an underlying malignancy, making it crucial to thoroughly investigate patients for cancer. A CT scan of the chest, abdomen, and pelvis is the most reliable and efficient method for detecting any potential malignancy. While a chest x-ray may identify lung cancer, it is not as accurate and may miss tumors in other areas. An MRI of the brain is unlikely to be helpful as intracerebral pathology is not typically associated with dermatomyositis. The most common cancers associated with dermatomyositis are lung, breast, and ovarian cancer. A PET scan may be used for staging and detecting metastases after an initial CT scan. An ultrasound of the MCP joints is unnecessary for diagnosis confirmation and would not be a reliable method for evaluating Gottron papules. A biopsy may be necessary if diagnostic uncertainty remains.

Dermatomyositis is a condition that causes inflammation and muscle weakness, as well as distinct skin lesions. It can occur on its own or be associated with other connective tissue disorders or underlying cancers, particularly ovarian, breast, and lung cancer. Screening for cancer is often done after a diagnosis of dermatomyositis. Polymyositis is a variant of the disease that does not have prominent skin manifestations.

The skin features of dermatomyositis include a photosensitive macular rash on the back and shoulders, a heliotrope rash around the eyes, roughened red papules on the fingers’ extensor surfaces (known as Gottron’s papules), extremely dry and scaly hands with linear cracks on the fingers’ palmar and lateral aspects (known as mechanic’s hands), and nail fold capillary dilation. Other symptoms may include proximal muscle weakness with tenderness, Raynaud’s phenomenon, respiratory muscle weakness, interstitial lung disease (such as fibrosing alveolitis or organizing pneumonia), dysphagia, and dysphonia.

Investigations for dermatomyositis typically involve testing for ANA antibodies, which are positive in around 80% of patients. Approximately 30% of patients have antibodies to aminoacyl-tRNA synthetases, including antibodies against histidine-tRNA ligase (also called Jo-1), antibodies to signal recognition particle (SRP), and anti-Mi-2 antibodies.